Relay Therapeutics Inc. (RLAY)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
19. 91
+0.54
+2.7878%
$
3.34B Market Cap
- P/E Ratio
- Div Yield
2.16M Volume
-2.94 Eps
$ 19.37
Previous Close 
Want to track RLAY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Relay Therapeutics Inc. (RLAY) Statistics
Valuation metrics
Market Cap 3.34B
Enterprise value 3.31B
Trailing P/E (ttm) -12.68
Forward P/E -
PEG ratio -0.34
Price/Sales (ttm) 326.36
Price/Book (mrq) 5.58
Enterprise Value/Revenue 310.16
Enterprise Value/EBITDA -12.11
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 2.1M
Average volume (90 days) 4.13M
Price summary
52-Week low 3.02
52-Week high 20.79
Beta -
50-Day moving average 16.8
200-Day moving average 11.29
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -25.54%
Operating margin -27.77%
Operational effectiveness
Return on assets -0.39%
Return on equity -0.44%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.06
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.52
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.57
Total debt (mrq) -
Total Debt/Equity (mrq) 0.05
Current ratio (mrq) 22.13%
Book value per share (mrq) 3.57
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
